11-71473326-A-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_018161.5(NADSYN1):āc.508A>Cā(p.Ile170Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000217 in 1,614,080 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_018161.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NADSYN1 | NM_018161.5 | c.508A>C | p.Ile170Leu | missense_variant | 7/21 | ENST00000319023.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NADSYN1 | ENST00000319023.7 | c.508A>C | p.Ile170Leu | missense_variant | 7/21 | 1 | NM_018161.5 | P1 | |
NADSYN1 | ENST00000528509.5 | c.508A>C | p.Ile170Leu | missense_variant, NMD_transcript_variant | 7/10 | 1 | |||
NADSYN1 | ENST00000525200.5 | c.409A>C | p.Ile137Leu | missense_variant, NMD_transcript_variant | 6/21 | 2 | |||
NADSYN1 | ENST00000529120.5 | downstream_gene_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152208Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000278 AC: 7AN: 251452Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135900
GnomAD4 exome AF: 0.00000958 AC: 14AN: 1461872Hom.: 0 Cov.: 31 AF XY: 0.00000963 AC XY: 7AN XY: 727236
GnomAD4 genome AF: 0.000138 AC: 21AN: 152208Hom.: 0 Cov.: 34 AF XY: 0.000134 AC XY: 10AN XY: 74376
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 23, 2024 | The c.508A>C (p.I170L) alteration is located in exon 7 (coding exon 7) of the NADSYN1 gene. This alteration results from a A to C substitution at nucleotide position 508, causing the isoleucine (I) at amino acid position 170 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at